A polymorphic form of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt

PK139980AUndetermined Publication Date: 2009-02-24SMITHKLINE BEECHAM PLC
0 Cites 0 Cited by

Patent Information

Application Number
PK200000357
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2009-02-24
Patent Text Reader

Abstract

A polymorphic form of5-[4-[2-(N-methyl-N-(2-pyridyl)amino )ethoxy ]benzyl]thiazolidine-2,4-dione, maleic acid salt (the "Polymorph") characterised in that it provides: (i) an infra red spectrum containing peaks at 1752, 1546, 1154,621, and 602 cm- 1; and / or (ii) a Raman spectrum containing peaks at 1751,1243 and 602 cm-l; and / or (iii) a solid-state nuclear magnetic resonance spectrum containing peaks at 111.9, 114.8,119.6,129.2,134.0,138.0,144.7,153.2, 157.1, 170.7, 172.0 and 175.0ppm; and / or (iv) an X-ray powder diffraction (XRPD) pattern which gives calculated lattice spacing of 6.46, 5.39,4.83,4.68,3.71,3.63,3.58, and 3.48 Angstroms; a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
Need to check novelty before this filing date? Find Prior Art